BETA CAROTENE, LUTEIN/ZEAXANTHIN INTAKE LINKED TO LOWER RISK OF EYE DISEASE
This article was originally published in The Tan Sheet
Executive Summary
BETA CAROTENE, LUTEIN/ZEAXANTHIN INTAKE LINKED TO LOWER RISK OF EYE DISEASE in a case-control study evaluating the relationship between dietary intake of antioxidant vitamins and the risk of neovascular age-related macular degeneration that appears in the Nov. 9 issue of the Journal of the American Medical Association. The authors, Johanna Seddon, MD, Harvard School of Public Health, et al., concluded that "beta carotene and lutein/zeaxanthin were associated with a statistically significant trend for reduction in risk for AMD with higher intake, with an odds ratio of .59 for beta carotene and .43 for lutein/zeaxanthin, comparing the highest to the lowest quintile of intake for each."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning